Regulatory T cell therapy in autoimmune liver disease and transplantation
Open Access
- 12 March 2025
- journal article
- review article
- Published by Elsevier in JHEP Reports
- Vol. 7 (8) , 101394
Abstract
No abstract availableKeywords
Funding Information
- MRC (MR/Z506588/1)
This publication has 108 references indexed in Scilit:
- Global incidence and prevalence of autoimmune hepatitis, 1970–2022: a systematic review and meta-analysiseClinicalMedicine, 2023
- Mutations from patients with IPEX ported to mice reveal different patterns of FoxP3 and Treg dysfunctionCell Reports, 2023
- Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressiveEuropean Journal of Immunology, 2021
- A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantationHepatology, 2016
- Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipientsHepatology, 2013
- Human FoxP3+ regulatory T cells in systemic autoimmune diseasesAutoimmunity Reviews, 2011
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription FactorImmunity, 2009
- DNA methylation controls Foxp3 gene expressionEuropean Journal of Immunology, 2008
- Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell DeathImmunity, 2004
- Transplantation tolerance and immunosuppression following liver grafting in ratsImmunology Today, 1985